Association between lung immune prognostic index and survival of patients with metastatic urothelial carcinoma treated with pembrolizumab
ConclusionsLIPI, a simple and convenient score, could be a significant prognostic biomarker of OS, PFS, and DCRs for mUC treated with pembrolizumab.
Source: International Journal of Clinical Oncology - Category: Cancer & Oncology Source Type: research
More News: Cancer & Oncology | Carcinoma